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Abstract
Background: Epigenetic mechanisms such as chromatin accessibility impact transcription factor binding to DNA
and transcriptional specificity. The androgen receptor (AR), a master regulator of the male phenotype and prostate
cancer pathogenesis, acts primarily through ligand-activated transcription of target genes. Although several
determinants of AR transcriptional specificity have been elucidated, our understanding of the interplay between
chromatin accessibility and AR function remains incomplete.
Results: We used deep sequencing to assess chromatin structure via DNase I hypersensitivity and mRNA
abundance, and paired these datasets with three independent AR ChIP-seq datasets. Our analysis revealed
qualitative and quantitative differences in chromatin accessibility that corresponded to both AR binding and an
enrichment of motifs for potential collaborating factors, one of which was identified as SP1. These quantitative
differences were significantly associated with AR-regulated mRNA transcription across the genome. Base-pair
resolution of the DNase I cleavage profile revealed three distinct footprinting patterns associated with the AR-DNA
interaction, suggesting multiple modes of AR interaction with the genome.
Conclusions: In contrast with other DNA-binding factors, AR binding to the genome does not only target regions
that are accessible to DNase I cleavage prior to hormone induction. AR binding is invariably associated with an
increase in chromatin accessibility and, consequently, changes in gene expression. Furthermore, we present the
first in vivo evidence that a significant fraction of AR binds only to half of the full AR DNA motif. These findings
indicate a dynamic quantitative relationship between chromatin structure and AR-DNA binding that impacts AR
transcriptional specificity.
Background
The androgen receptor (AR), a ligand-activated member
of the nuclear receptor superfamily, plays a critical role
in the male phenotype and prostate cancer biology. AR
expression results in context-specific transformation of
prostate epithelial cells [1-5], and persistent AR signaling
is implicated in the progression to castration-resistant
prostate cancer [6-8]. However, AR activity can be alter-
natively associated with promotion or inhibition of
growth. For example, AR activation by androgen induc-
tion limits proliferation in some immortalized prostate
epithelial cells expressing AR [2,9], whereas AR activation
most often increases proliferation in human-derived
prostate cancer cell lines with endogenous AR expression
(for example, LNCaP [10], LAPC-4 [11] and VCaP [12]).
As the AR acts primarily through transcriptional activa-
tion of target genes, it is critical to understand the deter-
minants of the AR-mediated transcriptional program.
AR-mediated transcriptional specificity is highly regu-
lated, and the AR associates with proteins that possess
co-activator or co-repressor function [13]. AR binding
to chromatin, similar to many transcription factors, is
thought to occur in competition with nucleosome histone
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proteins, the core organizational component of chromatin
[14]. Several identified AR co-factors either possess an
intrinsic chromatin remodeling capability or are able to
bind and recruit other chromatin modifying enzymes and
facilitate AR binding. Indeed, the binding of AR to DNA
across the genome (the AR cistrome) is modulated by the
primary DNA sequence, chromatin structure around the
AR and/or co-factor binding sites and other factors such
as FOXA1, a member of the forkhead box (FOX) and
hepatocyte nuclear factor transcription factor families [15].
Recent reports examining nucleosome positioning in
relation to AR binding have found that local nucleo-
some depletion and increased chromatin accessibility
accompanies the AR binding to DNA [16,17]. However,
while one study observed a clear decrease in occupancy
of histone 3 (H3) dimethyl lysine 4 (H3K4me2)-marked
nucleosomes over AR binding sites and a concomitant
increase in occupancy at flanking nucleosome positions
[16], another found that the nucleosome depletion size
was not increased by AR occupancy but rather nucleo-
some dynamics were affected by the receptor binding
[17]. Interestingly, nucleosome depletion at the three
enhancers studied was evident both before and after
hormone treatment. Thus, chromatin structure is likely
to impact the interaction between the AR and DNA,
and ligand activation of the AR may result in altered
chromatin structure. Our complete understanding of
this process remains quite limited and, consequently, a
comprehensive genome-wide analysis of AR function is
needed.
The mapping of DNase I hypersensitive (DHS) sites is
an accurate method to identify different types of active
gene regulatory elements within accessible chromatin
[18-20]. More recent high-throughput identification of all
DHS sites within a single cell type using DNase-seq show
high correlations with active histone modifications, regions
of nucleosome depletion detected by Formaldehyde
Assisted Isolation of Regulatory Elements (FAIRE) and
transcription factor binding sites [21-24]. Changes in
DNase I cleavage patterns have been observed at specific
loci bound by nuclear receptors, supporting the finding
that at least some nuclear receptors can disrupt chromatin
structure [25]. The single-base-pair resolution digestion
patterns from DNase-seq can identify footprints of local
DNA protection that accurately predict transcription fac-
tor-DNA binding [26-28]. Thus, in a single experiment,
DNase-seq can identify both larger nucleosome-depleted
regions and finer resolution transcription factor binding
sites within nucleosome-depleted regions.
To determine the relationship between AR-dependent
chromatin accessibility changes and AR-mediated tran-
scription, we performed DNase-seq and mRNA-seq on
the well-established androgen-sensitive prostate cancer
cell line LNCaP, before and after hormone induction. AR
binding sites were obtained from three published studies
describing AR ChIP-seq experiments on LNCaP cell
lines. Another member of the nuclear receptor superfam-
ily, the glucocorticoid receptor (GR), was recently found
to bind predominantly in DHS sites that exist prior to
GR ligand hormone treatment [29]. In agreement with
another recently published study [30], we find that a sub-
stantial amount of AR binding occurs in accessible chro-
matin after hormone induction. In contrast to the GR,
approximately half of these AR sites bind in DHS sites
that exist prior to AR activation, with the remaining sites
becoming accessible after AR activation. AR binding also
significantly increases chromatin accessibility. Quantita-
tive changes in chromatin structure correlate with AR-
dependent differential gene expression and are enriched
for transcription factor-DNA binding motifs that offer
insight into the mechanism of AR-induced chromatin
remodeling. Intriguingly, fine resolution DNase-seq pro-
files surrounding AR DNA binding motifs provides
in vivo evidence of AR binding to both half and full AR
DNA recognition motifs. Together, our work reveals that
active chromatin remodeling occurs during androgen
nuclear receptor activation.
Results
DNase-seq identifies changes in chromatin accessibility
with androgen receptor activation
To assess the relationship between accessible chromatin
and AR activation, we performed DNase-seq on indepen-
dent growths of LNCaP cells that were cultured with
(LNCaP-induced) or without (LNCaP) the synthetic
androgen R1881 (12 hours). Using previously published
methodologies and a standard analysis pipeline [31], we
identified the full spectrum of DNase-seq signal across
the genome (Figure 1a). We approached interpretation of
DNase-seq data in two ways: calling discrete peaks,
referred to as DHS sites, and comparing regions qualita-
tively as binary conditions (DHS site or not); and identi-
fying regions of statistically different DNase-seq signal
before and after hormone treatment, referred to as
ΔDNase regions.
From approximately 130 million post-filter sequence
reads per growth condition, we identified 144,070 DHS
sites in LNCaP and 140,966 DHS in LNCaP-induced
cells using a P-value cutoff of 0.05. The DHS sites in
each cell condition cover approximately 3% of the
human genome (Table S1 in Additional file 1). A com-
parison of the DHS sites identified in LNCaP-induced
and LNCaP reveals that 102,173 (72.5%) of sites overlap.
To put the degree of overlap in context, we used the
same criteria to identify DHS sites in seven unrelated
cell lines for which high quality DNase-seq data is avail-
able (NHEK, GM12678, HelaS3, HepG2, HUVEC, K562
and H1-ES) [24]. The average overlap between distinct
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cell lines is 50.4% ± 7.04%, which is substantially less
than the overlap between LNCaP and LNCaP-induced
(Figure 1b,c). We also investigated the overall distribu-
tion of DHS sites relative to genic elements and found
that AR activation does not shift this distribution
(Figure 1d). These data suggest that although AR activa-
tion induces a modest amount of chromatin changes,
the degree of these changes is substantially less than
those detected between cell lines from unrelated tissues.
To quantitatively identify those loci with the most sub-
stantive increase or decrease in DNase-seq signal with
AR activation, we used the edgeR statistical package [32].
Increases represent regions that become more accessible
after hormone treatment, and decreases become less
accessible. To capture a broad spectrum of significant
changes in signal, we used two statistical thresholds
(strict = a false discovery rate (FDR) threshold of 5%, and
loose = unadjusted P-value threshold of 0.05) to identify
the degree of accessibility changes, which we refer to as
ΔDNase regions. At the strict threshold, we identified
2,586 regions with strict ΔDNase increase after androgen
induction and no regions of signal decrease. The loose
threshold identified 18,692 regions with loose ΔDNase
increase and 1,467 regions with loose ΔDNase decrease
(Table 1). These regions suggest that AR activation
results primarily in regions with increased rather than
Figure 1 Identification of DNase I hypersensitive sites in LNCaP cells before and after R1881 stimulation. (a) DNase-seq signal is a
continuous signal across the genome. We illustrate the chromatin accessibility around the KLK locus before and after hormone induction. Each
sample has a fixed y-axis DNase-seq score of 0.7. (b) Overlap between DHS sites identified before and after hormone as compared to the
unrelated cell line HepG2. (c) Spearman correlation heatmap of the union set of top 100,000 DHS peaks in each of the nine cell lines illustrated.
(d) Distribution of all DHS sites relative to genic elements. DHS: DNase I hypersensitive; DNase-seq: DNase I hypersensitivity analysis coupled with
high-throughput sequencing; kb; kilobase pairs; TSS: transcription start site.
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decreased chromatin accessibility (Figure 2a, Figure S1A
in Additional file 1).
To ensure that the observed trend towards higher
levels of open chromatin is not a bias related to the
edgeR algorithm, we also calculated a normalized differ-
ential DNase-seq tag count for each region in the union
set of LNCaP-induced and LNCaP DHS sites (Materials
and methods). This differential count also indicated that
more regions display an increase in DNase-seq signal
with androgen treatment, supporting the edgeR results
(Figure S1B,C in Additional file 1).
Mapping all regions of significantly changed DNase-seq
signal to genic elements revealed a depletion of promoter
regions and enrichment for both inter- and intragenic
locations compared with all DHS sites (Figure 2b, Figure
S1D in Additional file 1). For example, approximately 8%
of loose ΔDNase increases map to promoters (defined as
2 kb region upstream of the transcriptional start site)
whereas close to 15% of all DHS sites fell within promo-
ters. The opposite trend was seen for sites that overlapped
the first exon and/or intron and sites contained within
intergenic regions. Thus, our data show that AR activation
primarily results in increased chromatin accessibility in
distal regulatory elements that may be associated with
Table 1 Number of differential regions of DNase-seq with
androgen receptor activation (ΔDNase).
Strict threshold Number of regions
Strict ΔDNase increase 2,586
Strict ΔDNase decrease 0
Loose threshold
Loose ΔDNase increase 18,692
Loose ΔDNase decrease 1,467
ΔDNase regions were identified using edgeR (Materials and methods). Strict
ΔDNase increases are a complete subset of the loose ΔDNase increase
regions.
Figure 2 Identification of differences in DNase-seq signal. (a) Top panel: distribution of tags per ΔDNase windows in LNCaP versus LNCaP-
induced. Bottom panel: distribution of DNase-seq tags in union regions used to identify ΔDNase increases and decreases. (b) Distribution of
ΔDNase regions and all union (of LNCaP and LNCaP-induced) DHS regions relative to genic elements. (c) Replicates of DNase-seq data around
KLK3 and KLK2. Y-axis is fixed to range from 0 to 0.4 for all rows. Highlighted regions marked by an asterisk represent examples of significant
ΔDNase increases. (d) Significant motifs identified de novo in ΔDNase gain and loss regions. DHS: DNase I hypersensitive; DNase-seq: DNase I
hypersensitivity analysis coupled with high-throughput sequencing; kb; kilobase pairs; TSS: transcription start site.
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enhancer rather than proximal promoter function, exem-
plified by a well-characterized AR enhancer [33] 4 kb
upstream of the kallikrein 3 (KLK3) promoter (Figure 2c).
We hypothesized that ΔDNase regions represented
locations where AR activation altered transcription factor
binding. As expected, we found a strong AR motif match
in regions of increased open chromatin (Materials and
methods). In addition, several other significantly enriched
motifs were detected in both ΔDNase increase and
decrease regions (Figure 2d, Table S2 in Additional file 1)
that correspond to transcription factors such as specifi-
city protein 1 (SP1). We also detected enrichment of an
SP1 DNA recognition motif within DHS sites using a
self-organizing map (SOM) (Materials and methods) that
identifies highly specific LNCaP-only DHS regions that
were not accessible in 113 additional cell lines (Figure
S1E in Additional file 1, top panel). The SOM analysis
also identified an enriched motif corresponding to E2A/
TCF3 as well as FOXA1 (Figure S1E, middle panel and
bottom panels). SP1 can bind directly with multiple
known AR co-factors as well as the AR [34]. TCF3 is
involved in the Wnt/b-catenin signaling pathway, which
crosstalks with AR signaling in prostate cancer [35].
ΔDNase increases were also enriched for a yin and yang
1 (YY1) motif, which is a transcription factor with a
known role in AR-mediated transcription [36]. To com-
pare how often these motifs are found in ΔDNase regions
relative to other DHS sites, we calculated a relative
enrichment score reflecting the relative frequency that a
motif match is found in either set of regions. The score
for the AR (4.82) and AR+FOXA1 (2.36) motifs suggests
they are more commonly found in ΔDNase regions,
whereas the score for SP1 (0.45) suggests that this motif
is more commonly found in regions in which chromatin
accessibility does not change with AR activation. The
score for YY1 (1.05) indicates that the motif is found
with almost equal frequency in ΔDNase regions and
other DHS sites. ΔDNase regions that underwent a
decrease in chromatin accessibility with AR activation
did not exhibit an enrichment of the AR motif, but we
uncovered a motif consistent with activator protein 2,
which has been implicated in estrogen receptor binding
and function [37], and its DNA motif is found in the pro-
moter regions of several AR-regulated genes in prostate
cancer [38]. Thus, AR activation changes chromatin
accessibility in regions with AR and AR co-factor binding
motifs, likely due to changes in transcription factor load-
ing at these genomic regions.
The androgen receptor binds both poised and remodeled
chromatin accessible to DNase I cleavage
Based on our motif analysis of ΔDNase regions and
recent reports of AR binding to nucleosome-depleted
regions marked by acetylated H3 [17] and H3K4me2
[16], we hypothesized that the AR binds primarily in
DHS sites. We therefore used three sets of AR ChIP-seq
data from LNCaP cells (Table 2) that we refer to as Yu
[39], Massie [40] and Coetzee [17,41]. To minimize the
impact of technical variation within each individual
experiment, we created two high confidence sets of AR
binding sites from these three sources: an ‘R1881 inter-
sect’ set consisting of Yu and Massie peaks that overlap
each other, as these experiments used the same AR hor-
mone ligand as our DNase-seq experiments (R1881);
and an ‘All AR Intersect’ dataset containing the intersec-
tion of peaks from all three data sets including the
Coetzee experiment that used an alternative AR ligand,
dihydrotestosterone. Intersecting AR ChIP datasets did
not change the distribution of identified binding sites
relative to genic elements (Figure S2A in Additional file
1), despite substantially reducing the number of total
AR binding regions by including only those common to
two or more experiments (Table 2).
Each of the three individual AR ChIP studies displayed
consistent overlap patterns with DHS sites. In each indi-
vidual experiment approximately 20% of all AR binding
sites occurred within DHS sites that are present both
before and after hormone treatment (poised DHS sites).
An additional 20% to 30% of AR binding sites over-
lapped DHS sites following androgen induction. Thus,
results from each dataset suggest that slightly less than
half of all AR binding sites in DHS regions are poised
(Figure 3a,b) and the remainder change in response to
androgen treatment. The high confidence AR (R1881
intersect and All AR Intersect) binding sites displayed a
similar trend. Of note, only 1% to 2% of AR binding
sites map within a DHS site present in LNCaP but not
LNCaP-induced cells. The amount of AR binding to
both poised and LNCaP-induced DHS sites (Figure S2B
in Additional file 1) is in stark contrast to Myc and
CCCTC-binding factor (CTCF) binding sites [24] that
almost exclusively bind within poised DHS sites (Figure
3a). Thus, of the AR binding events occurring within a
DHS site, approximately half occurred in poised regions,
Table 2 Characteristics of androgen receptor ChIP-seq
datasets.
Dataset Number of androgen receptor
binding sites
Massie 19,505
Yu 37,676
Coetzee 12,929
R1881 intersect (Massie/Yu
intersect)
13,258
All AR Intersect 5,940
Number of peaks called for each AR ChIP-seq dataset. R1881 intersect
represents the intersection of the Massie and Yu datasets. All AR Intersect
represents high confidence androgen receptor binding sites that are found in
all three datasets.
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with the majority binding to regions that displayed qua-
litative AR-induced chromatin remodeling.
Given the observation that a substantial number of AR
binding sites occur within LNCaP-induced only DHS sites,
we examined the association between AR binding events
and quantitative chromatin remodeling. To test this, we
evaluated AR sites that overlapped regions with increased
DNase-seq signal (strict and loose ΔDNase increases). As
expected, AR ChIP-seq peaks identified only within
LNCaP-induced DHS sites (Region III, Figure 3c) show
significant overlap with ΔDNase increase regions. Interest-
ingly, AR binding sites in peaks found in both LNCaP and
LNCaP-induced cells (Region II, Figure 3c) were also
enriched for ΔDNase increases, although not to the same
extent as those sites that mapped only within LNCaP-
induced DHS sites. The proportions of AR binding regions
Figure 3 Relationship between androgen receptor binding and DNase I hypersensitivity. (a) Overlap of each ChIP-seq AR binding peaks
with poised LNCaP DHS (regions that are DHS sites in both LNCaP and LNCaP-induced) and LNCaP-induced only DHS sites. AR binding sites not
overlapping a DHS site are represented in black. Common Myc and CTCF binding sites are shown as control. (b) Overlap of ChIP-seq peaks is
shown at different thresholds of DNase-seq enrichment (’DHS sites’ representing regions of significant signal over background P < 0.05, ‘Top
200k’ representing the top 200,000 initial peaks showing enrichment over background, and ‘Top 400k’ representing all regions showing DNase-
seq enrichment over background). Columns in various shades of blue show overlap with LNCaP DHS at different thresholds, and columns in
various shades of red show overlap with LNCaP-induced DHS at different thresholds. Common Myc and CTCF binding sites [24] are included as
control. (c) Overlap between ΔDNase regions and AR binding sites in the context of AR binding sites that overlap with DHS sites. Shown are
data for All AR ChIP-seq intersect peaks. Region I represents AR binding sites in LNCaP DHS sites only, Region II contains AR binding sites in a
region that is both a LNCaP DHS site and LNCaP-induced DHS site (poised), and Region III represents AR binding sites in a region that is only a
LNCaP-induced DHS site. Bottom figure shows overlap with ΔDNase strict and loose gain as well as loose decreases. Each region of overlap (I, II,
III) is indicated by a different shade of purple. (d) AR ChIP-seq binding scores for peaks overlapping and not overlapping DHS sites as measured
by MACS. Starred data points denote significant differences in AR peak score (Mann-Whitney P-value < 0.001). (e) De novo motif analysis of
regions containing an AR ChIP-seq peak (All AR Intersect) and very low DNase-seq signal (black bars in Figure 3B) reveals a motif closely
matching that of the AR, with a noticeable variation in the typically degenerate region (black arrow). (F) De novo motifs identified in ΔDNase
regions that do not overlap AR ChIP-seq peaks (All AR Intersect). AR: androgen receptor; CTCF: CCCTC-binding factor; DHS: DNase I
hypersensitive; DNase-seq: DNase I hypersensitivity analysis coupled with high-throughput sequencing.
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that mapped to poised, LNCaP-induced DHS sites only
and to ΔDNase regions were consistent across each AR
binding data set (Figure S2C in Additional file 1). Analo-
gously, we found that 36.5% of strict ΔDNase increases
and 16.7% of loose ΔDNase increases overlapped the high
confidence AR binding set (All AR Intersect) (Figure S2D
in Additional file 1). These observations indicate that
although AR binding occurred within DNA in a poised
open chromatin state, a substantial increase in chromatin
accessibility occurred in many of these regions after AR
activation. This highlights the utility of identifying regions
of ΔDNase signal in addition to regions that simply cross
the binary threshold of becoming a DHS site with andro-
gen induction. These findings support similar observations
at three previously identified poised AR enhancers [17]
and suggest that AR binding more globally stabilizes DHS,
allowing for more DNase I cleavage after hormone
treatment.
A large percentage of AR binding sites detected by each
of the individual AR ChIP-seq datasets (approximately
50%) did not overlap DHS sites. To determine if this is
due to a peak-calling threshold, we decreased the strin-
gency threshold for identifying DHS sites to either the top
200,000 or top 400,000 DNase I sensitive regions. Overlap
with AR ChIP-seq indicates that the proportion of AR
binding sites binding in a poised versus qualitatively remo-
deled region was consistent regardless of the threshold,
and that a substantial proportion of AR binding occurs in
non-DNase I sensitive regions of the genome even after
relaxing the DHS peak thresholds (Figure 3b). Even after
increasing the sequencing depth two-fold, which increased
the overall overlap of DHS sites with high confidence AR
binding sites, 40% of these binding sites remained only
within an induced DHS site (data not shown). In addition,
the AR binding signal was stronger in regions overlapping
DHS sites than non-DHS regions (Figure 3d), and was the
strongest for AR sites common to two or three experi-
ments. Thus, it appears that AR binding occurs at sites
with a range of DNase I sensitivity and DNase I sensitivity
correlates with AR binding strength.
Finally, we examined several different combinations of
regions for evidence of differential co-factor requirements
using de novo motif analysis. First, we searched for motifs
enriched in AR binding sites defined by ChIP-seq peaks
that did not map within DHS sites. Only one motif was
enriched within these regions by our de novo analysis,
which resembled both the canonical AR motif and a motif
derived de novo from AR ChIP-seq sequences that fall
within poised DHS sites (Figure 4a), but displayed an
increased invariant nucleotide within the degenerate 3 bp
region between half sites (Figure 3e). Scanning these same
regions against annotated motifs revealed enrichment,
albeit with lower match scores, of motifs commonly asso-
ciated with AR binding (Table S3 in Additional file 1).
These results suggest that AR binding in regions of very
low DNase-seq signal may be less associated with AR co-
factors. We separated strict and loose ΔDNase increase
regions into regions with and without an AR ChIP-seq
peak (from All AR Intersect set) and searched for enriched
motifs de novo. ΔDNase regions overlapping AR binding
were enriched for motifs matching the AR and FOX family
members, as expected. ΔDNase regions without AR bind-
ing were enriched for several high information content
motifs including those for paired-like homeodomain tran-
scription factor 2 (PITX2) and CTCF (Figure 3f, Table S3
in Additional file 1).
Changes in chromatin accessibility correlate with the
androgen receptor transcriptional program
To compare ΔDNase regions to the AR-mediated tran-
scriptional program, we generated mRNA-seq data under
conditions matched to our DNase-seq experiments and
identified genes differentially regulated by androgen induc-
tion. Three replicates were generated and their expression
values clustered according to hormone treatment status
(Figure S3A in Additional file 1). Using edgeR [32], we
identified 339 genes differentially expressed upon AR
induction (FDR < 0.05), 202 of which were upregulated
and 137 of which were downregulated (Figure 5a, Addi-
tional file 2). Of these, 46% were identified as AR target
genes in at least one other study (Additional file 3).
We hypothesized that AR-mediated changes in chroma-
tin accessibility contribute to the AR-mediated gene
expression program. By mapping ΔDNase regions to the
closest transcriptional start site (Figure 5b), we found that
strict ΔDNase increase regions were significantly enriched
near upregulated genes (P < 0.001). Loose ΔDNase
increases were significantly enriched near both up- and
downregulated genes (P < 0.001). We noticed that both
strict ΔDNase increases and loose ΔDNase decreases were
enriched near downregulated genes with borderline signif-
icance. The reverse comparison, in which we associated
differentially regulated genes to ΔDNase regions within
20 kb of the transcriptional start site (Figure S3C in Addi-
tional file 1), confirmed the strongly significant trends
mentioned. By contrast, the borderline significant associa-
tions disappeared in this reverse comparison, and
also when we limited our analysis from Figure 5b to a dis-
tance cutoff of 25 kb. We performed an identical analysis
using ΔDNase regions and microarray expression data
from Massie et al. [40], and observed similar associations
(Figure S3B,D in Additional file 1). We also examined the
association between AR binding events with very low
DNase-seq signal and AR-regulated genes, and found
these regions were not significantly enriched around either
up- or downregulated genes (data not shown). Overall,
our data support the hypothesis that AR activation prefer-
entially causes distal increases in chromatin accessibility
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that significantly correlate with nearby gene expression
changes.
Base-pair resolution analysis of DNase-seq reveals
multiple signal profiles
Our group and others have shown that DNase-seq can
detect individual transcription factor binding events via
the identification of DNase I footprints and that DNase I
footprints correspond to local protection of DNA from
nuclease cleavage by bound transcription factors [26-28].
An overall increase in DNase signal was observed around
AR motifs (Figure 4a) compared with other transcription
factor motifs such as CTCF and neuron-restrictive silencer
factor (NRSF) (Figures 4b,c). A symmetrical depletion of
DNase-seq signal was detected around AR motifs in DHS
sites that closely matches the information content of the
AR binding motif dimer (Figure 4a, red line) [42]. In
poised AR binding sites, we observed a similar pattern of
protection despite lower overall DNase-seq signal intensity
(Figure 4a, blue line). Binding sites that became available
only after androgen induction only exhibited the footprint
after androgen treatment (Figure 4d, blue line). Impor-
tantly, the overall enrichment of DNase signal in LNCaP-
induced cells is specific to DHS regions that bind the
AR and have an AR motif, as opposed to all DHS sites
(Figure 4e). The observed evidence of AR motif protection
prior to androgen induction (Figure 4a) may represent
binding of an alternate factor that is displaced upon AR
activation, such as has been reported for specific loci by
GATA binding protein 2 [17]. From the compendium of
cell lines that have been processed for DNase-seq through
the ENCODE project, we identified H1 embryonic stem
cells and D721 medulloblastoma cells as having relatively
low expression levels of the AR. DNase-seq signal around
AR motifs within DHS sites in these two cell lines resem-
ble that of LNCaP cells prior to hormone treatment
Figure 4 Base-pair resolution around androgen receptor motif matches reveals a unique pattern of protection by the androgen
receptor. (a) Aggregate plot of DNase-seq signal around AR motif matches within poised DHS sites that also bind the AR. The pattern of DNase
I cuts within the motif closely follows the known structure of the AR dimer as well as the information content of the AR DNA recognition motif
determined de novo from ChIP-seq sequences that overlap DHS sites. (b) Aggregate DNase-seq signal centered around CTCF motif and (c)
neuron-restrictive silencer factor (NRSF) matches genome-wide displaying a structurally different footprint from that of the AR. (d) Aggregate
plot of DNase-seq signal around AR motif matches within DHS sites unique to LNCaP-induced cells that also bind the AR. (e) Aggregate plot of
DNase-seq signal around the centers of 10,000 randomly sampled DHS sites shared between LNCaP and LNCaP-induced cells. Note that overall
the aggregate signal is higher in LNCaP as compared to LNCaP-induced cells within all DHS sites. AR: androgen receptor; CTCF: CCCTC-binding
factor; DHS: DNase I hypersensitive; DNase-seq: DNase I hypersensitivity analysis coupled with high-throughput sequencing; NRSF: neuron-
restrictive silencer factor.
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(Figure S4A in Additional file 1), suggesting that such a
protection pattern in non-AR activated cell lines could
result from alternative transcription factor binding to
DNA at these regions.
To further investigate the AR footprint we performed k-
means clustering to search for discrete DNase-seq patterns
around AR motif matches (Materials and methods).
DNase-seq signal was represented by a vector of DNase I
cuts spanning 15 bp around the center of the AR motif.
We identified three reproducible clusters, each of which
represented part of the observed composite footprint
(Figure 6a). These clusters were much less frequently
detected across repeated iterations of clustering in
untreated LNCaP cells. To quantify the degree to which
these three patterns were present in LNCaP-induced cells
compared with untreated cells, we examined the correla-
tion between cluster centers obtained by performing
k-means clustering 100 times for induced and uninduced
LNCaP DNase-seq data. Specifically, the correlation of
each cluster center to the cluster centers from all previous
iterations was computed. Correlations tightly distributed
around 1.0 represent highly reproducible clusters across
different runs, suggesting that the three patterns are
robust and consistently observed at AR motifs. Correla-
tions loosely distributed about values less than 1.0 indicate
that the three DNase-seq patterns at AR motif matches
are less reproducible. We found this correlation distribu-
tion to be significantly higher (Mann-Whitney P < 2.2e-16)
for LNCaP-induced cells (Figure 6b), with the most robust
clustering associated with AR binding (Figure S4B in
Additional file 1) (Mann-Whitney P < 0.001 between each
column of correlations). Increasing the value of k consis-
tently identified the same three general patterns in
LNCaP-induced DNase-seq data within the AR motif,
with multiple clusters aggregating to each general pattern
(Figure S4E in Additional file 1). Using correlation analysis
to analyze clusters from different values of k revealed that
k = 3 is the most appropriate value (Figure S4F in Addi-
tional file 1), supporting that three distinct patterns of
DNase I cleavage exist within AR motifs. Overall, the
three distinct patterns of DNase I protection appeared to
be a robust phenomenon more often detected in LNCaP-
induced DNase-seq data, suggesting that AR activation
stabilizes specific chromatin structure around AR motifs.
AR binding has been associated with enrichment of
palindromic full-site AR motifs (such as depicted in
Figure 4a) as well as half-site motifs [43,44]. The direc-
tional footprinting in clusters 1 and 2 is indicative of
only half of the full canonical AR motif being protected
from DNase I cleavage, whereas cluster 3 is consistent
with full-site protection. Our ability to detect this indi-
cates that specific half-site usage is consistent across the
Figure 5 ΔDNase regions are associated with androgen receptor-regulated transcription. (a) Heatmap of mRNA-seq expression levels
(natural log of reads per kilobase mapped expression value) for genes identified as differentially regulated by the AR. Rows are ordered by total
sum. Genes most commonly identified in microarray studies as AR-regulated are all located near the top of the heatmap, indicating overall high
levels of expression before and after hormone induction. (b) ΔDNase changes randomly permuted against mRNA-seq identified up- and
downregulated genes. ΔDNase regions were mapped to the closest gene, and the amount of overlap between these genes and the
differentially expressed set was permuted 100,000 times to assess significance. Arrows indicate the actual overlap between ΔDNase nearest genes
and mRNA-seq regulated genes relative to random permutations. Blue shading represents less ΔDNase regions (absence/depletion) around
regulated genes than expected by chance. Yellow shading represents more ΔDNase regions (presence/enrichment) present around regulated
genes than expected by chance. AR: androgen receptor; mRNA-seq: messenger RNA abundance measured by high-throughput sequencing.
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entire population of cells, and does not fluctuate ran-
domly. The spike in the center of cluster 3 corresponds
to the degenerate bases in the middle of the AR motif,
indicating reduced DNA protection between AR pro-
teins within the dimer. A recent report examining the
dynamics of AR dimerization showed, in an exogenous
system, that the AR binding enhancer element of
TMPRSS2 requires an AR dimer. Consistently, we
observed a DNase-seq digestion pattern similar to that
shown in cluster 3 within this enhancer element (Figure
S4D in Additional file 1).
While we posited that full-site protection might reflect a
stronger AR-DNA association, AR ChIP-seq peak scores
were evenly distributed between the three clusters, sug-
gesting similar binding strength (Figure S4C in Additional
file 1). We next explored if each cluster exhibited different
co-factor motif enrichment by de novo motif analysis of
the 25 base pairs upstream and downstream of the motif
clusters (Figure 6c). Within these intervals, we detected
more significant enrichment of FOX family motifs in the
highly protected portions (dips) of clusters 1 and 2.
A motif consistent with NF1C, which was also detected in
an analysis of ΔDNase regions (Table S3 in Additional
file 1), was enriched only upstream of cluster 3. These ana-
lyses suggest that the two well-defined dips observed
around the composite footprint (Figure 4a) correspond to
Figure 6 AR binding displays three distinct modes of androgen receptor-DNA interaction that are specific to ligand-activated androgen
receptor. (a) K-means clustering of LNCaP-induced DNase-seq signal into three consistent clusters within AR binding sites. (b) K-means clustering (k =
3) was repeated 100 times on both LNCaP and LNCaP-induced DNase-seq data around all DHS sites with a full-site canonical AR motif. Shown is the
distribution of correlations between cluster centers for each run. The asterisk denotes the statistically significant difference between the correlation
distributions (Mann-Whitney P < 2.2e-16). (c) Motif analysis of the entire 25 bp span up- and downstream from AR motif matches for each cluster.
MEME motifs identified within this interval (E < 0.1, E-value shown below logo) are shown in logo format. Motifs that significantly match a known
motif (E < 0.05, by TomTom) are marked with an asterisk. The name of the most significant match according to TomTom is indicated next to the logo,
as is the percentage of regions that contain the enriched motif. For matches resembling FOX family factors, we note that these motifs are very similar
to each other. DNase-seq signal is shown as the aggregate signal from all cluster members with the dotted lines marking the location of the AR motif
within the plot. AR: androgen receptor; bp: base pairs; DHS: DNase I hypersensitive; DNase-seq: DNase I hypersensitivity analysis coupled with high-
throughput sequencing; FOX: Forkhead box; NF1C: nuclear factor 1 C-type.
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FOX factor-mediated DNA protection, which is seen to a
more noticeable degree in LNCaP-induced DNase-seq
data. Overall, our footprinting analysis revealed three dif-
ferent stable modes of DNase-seq protection with AR
binding that represent two phenomena: full- or half-site
protection at full-site DNA motifs.
Discussion
The AR is a transcription factor and a primary driver of
prostate cancer. Understanding the key determinants of
its transcriptional specificity remains a critical issue. By
integrating analysis of DNase-seq data with AR ChIP-seq
and mRNA-seq, we showed that AR activation induced
genome-wide changes in chromatin structure that were
associated with AR binding and transcriptional response.
We also uncovered multiple modes of AR utilization of
its DNA recognition motif. Although a subset of AR
binding occurs in qualitatively poised chromatin exhibit-
ing nucleosome depletion prior to hormone treatment,
we demonstrated that AR binding is consistently asso-
ciated with a quantitatively significant increase in DNase-
seq signal, suggesting stabilization of nucleosome deple-
tion and chromatin remodeling.
Several prior reports also support AR-induced chroma-
tin remodeling [16,17], including a very recently published
study utilizing DNase-seq by He et al. [30]. Our data com-
bined with these prior reports suggest a different model
for nuclear receptor interaction with the genome than that
proposed by John et al. for the GR [29], where almost all
GR binding occurred in poised DHS sites. The AR and
GR, though possessing similar DNA-response elements,
seem to display fundamentally different interactions with
chromatin and DNA. Our data represent a significant
additional resource for understanding the association
between chromatin accessibility and nuclear receptor
function for several reasons. First, our DNase-seq experi-
ments were sequenced very deeply (approximately 130
million reads), which is similar to the depth of sequencing
with which John et al. observed GR binding to poised
chromatin. Second, we utilized a different AR ligand
(R1881) and time point of 12 hours as compared with 4
hours by He et al. and 1 hour by John et al. Similar to He
et al., who also utilized a quantitative measure of change
in DNase-seq signal, we observed that less than half of AR
binding targets poised chromatin and we were also able to
associate AR-induced chromatin remodeling with AR-
induced transcriptional changes, suggesting that the
mechanism of chromatin remodeling and its phenotypi-
cally relevant association with differential transcription
requires longer periods of receptor activation. Importantly,
we used a different statistical measurement of quantitative
change in DNase-seq signal to reach the same result and
conclusion. In our study and those by He et al. and John
et al., we note that the degree of nuclear receptor binding
within regions of poised chromatin decreases with
increased hormone treatment time (37% in He et al., 88%
in John et al. and 20% to 30% in our study). Although this
observation is confounded by differences in receptor,
receptor ligand, sequencing depth and DNase-seq protocol
among the mentioned studies, these data suggest that
more extensive comparative analyses over a full time
course of ligand stimulation of both AR and GR are
needed to fully understand the similarities and differences
of different hormone receptors with respect to their inter-
action with chromatin.
While the majority of high confidence AR binding
occurred in regions sensitive to DNase I cleavage, a sub-
stantial proportion of AR binding events occurred in
regions of low DNase-seq signal. It is possible that incon-
sistent and/or intermittent nucleosome depletion at these
genomic regions decreases DNA accessibility and limits
detection by our assay; this attribute of nucleosome deple-
tion appears to be associated with a slightly different AR
motif. Consistently, we also found that AR binding (as
measured by AR ChIP-seq signal intensity) is significantly
lower in non-DHS regions than in DHS regions. Thus, it
is plausible that regions that are identified with weaker AR
binding and lower DNase-seq signal may experience a
dynamic equilibrium of nucleosome and nuclear receptor
binding, as has been previously proposed [14]. Loci with
reduced DNase I cleavage and AR binding could reflect
low levels of AR binding at linker regions of non-displaced
nucleosomes or residual nucleosome occupancy, limiting
accessibility to DNase I cleavage in the cell population.
AR footprinting analysis further revealed the complexity
of the AR-DNA interaction. The aggregate DNase-seq sig-
nal around AR motifs demonstrated a relatively weak but
consistent pattern of protection that corresponds to the
expected binding pattern, consistent with other DNase I
footprinting studies [26]. In addition, we found three dis-
tinct patterns of DNase I protection significantly asso-
ciated with LNCaP cells treated with androgen. The
footprint patterns suggest that either AR binds to the full
AR consensus motif as a dimer (cluster 3) or only binds to
half of the motif (clusters 1 and 2). We also cannot
exclude the possibility that clusters 1 and 2 represent AR
dimers with only one AR molecule binding to half of the
consensus motif. AR binding to either half site did not
appear to be random, as evidenced by reproducible detec-
tion of distinct clusters. In other words, random binding
to either half site in a population of cells would not show
consistent half-site protection. Intriguingly, clusters 1 and
2 may provide the first in vivo and endogenous evidence
of functional AR monomers that have been suggested to
exist as a stable subpopulation of AR molecules [45]. Only
the AR binding sites that displayed a full-site dimer pro-
tection pattern (cluster 3) were enriched for the NF1C
motif, which is a known co-factor of AR. Therefore, there
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appears to be multiple modes that AR binds to canonical
DNA motifs in vivo, and these modes are associated with
different co-factors. These observations are consistent
with a recently proposed model of a transient interaction
between nuclear receptors such as the AR and DNA
rather than a stronger and more stable AR-DNA interac-
tion [46]. Our analysis also provides the first evidence of
substructure within a nuclear receptor footprint
The dynamics of AR-DNA binding are likely impacted
by additional co-factors that may facilitate AR binding
directly or indirectly. Distal regulatory elements identi-
fied by DNase-seq displayed an enrichment of SP1 and
E2A/TCF3 motifs within DHS specifically accessible in
LNCaP cells compared with 113 independent cell lines.
TCF3, a basic helix loop helix factor involved in Wnt/b-
catenin signaling [47,48], represents a new putative co-
factor for the AR that warrants further investigation to
understand its role in AR-mediated chromatin dynamics
as well as the crosstalk between AR and b-catenin signal-
ing. SP1 is especially interesting both because its motif
was enriched in ΔDNase regions and also in light of a
recent report that identified SP1 as necessary for the
expression of a variety of chromatin modifying enzymes,
such as the histone deacetylases 1 to 4 in LNCaP cells
[49]. Additionally, small molecule inhibitors of histone
deacetylases have been shown to decrease the growth
rate of AR-positive prostate cancer cell lines [50,51] and
disrupt AR-induced expression of its target genes [52].
Our relative enrichment score of less than one for the
SP1 motif and an observation that SP1 motifs often co-
localize with AR binding suggest complexity in the inter-
play between SP1 and the AR.
Conclusions
Overall, these lines of evidence combined with our
results warrant further investigation of SP1 in the context
of AR binding and AR-induced chromatin remodeling.
Our analyses show that qualitative and quantitative
assessment of chromatin accessibility by DNase-seq is an
important and useful tool for elucidating AR biology in
prostate cancer cell line models.
Materials and methods
Cell culture
LNCaP cells were obtained from ATCC and maintained
according to manufacturer instructions. Prior to cell
treatment with either 1 nM R1881 (methyltrienolone) or
vehicle (ethanol), cells were grown in Roswell Park
Memorial Institute-1640 media containing 10% char-
coal-dextran stripped serum for 60 hours.
DNase-seq library generation and analysis
DNase-seq was performed as previously described [24,53].
Briefly, 10 × 106 cells were harvested for each condition (±
androgen). Nuclei were extracted and digested with opti-
mal concentrations of DNase I enzyme. After confirmation
of adequate digestion, DNase I-digested ends were blunt
ended, and a biotinylated linker was ligated to these ends.
Fragments with linker attached were isolated, digested
with MmeI, and captured using streptavidin-conjugated
magnetic beads. A second linker was ligated to the MmeI-
digested end, and then the fragments were amplified and
subsequently purified via gel electrophoresis. These
sequencing libraries were sequenced on the Illumina
GAIIx sequencing platform (Illumina, San Diego, CA,
USA). Three biological replicates were processed for each
cell growth condition. Sequencing results were aligned to
the human reference genome (NCBI Build 37) using the
Burrows-Wheeler aligner (BWA)[54]. Alignments were fil-
tered to remove problematic repetitive regions such as
alpha satellites and PCR artifacts characterized by many
sequences mapped to small genomic locations. Biological
replicates were compared for reproducibility, and then
combined. In our cross-replicate analysis, we determined
one of three biological replicates of LNCaP-induced
DNase-seq to be discordant from the other two biological
replicates and thus removed that replicate from the com-
bined DNase-seq sequence set. The final base-pair resolu-
tion signal to reflect chromatin accessibility was generated
using F-seq [31]. Discrete peaks were called by fitting
DNase-seq signal data to a gamma distribution and then
determining the signal value that corresponded to P <
0.05. Gene-relative categories were defined as previously
described [24].
Identification of increases and decreases in DNase-seq
signal
To determine regions of significant change in DNase-seq
signal with androgen induction, we used the edgeR bio-
conductor package [32,55]. The edgeR package is designed
to detect differences in count data among groups of sam-
ples containing biological and technical replicates. Prior to
running the algorithm, we defined windows in which to
compare DNase-seq signal across replicates by first taking
the union set of all identified DHS sites in both LNCaP
and LNCaP-induced cells.
This approach allows for inclusion of regions that con-
tain an increase or decrease in DNase-seq signal such
that they cross the threshold defining a DHS site. The
defined union set was then divided into overlapping win-
dows of 300 bp. DHS regions smaller than the window
size were expanded to the window size. Regions larger
than the window size were tiled with overlapping win-
dows, where the overlap varies depending on the size of
the hypersensitive region to tile. We start by finding the
number of windows that would fit completely inside the
defined DHS site using the default overlap. If these win-
dows discard fewer than 10% of the bases on each edge
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of the DHS site, we tile the site using these windows. If
using the default overlap would cause us to lose more
than this edge threshold, we add another window and
adjust the overlap so that the windows exactly cover the
entire DHS region. We find that these windows cover
almost all of the DHS bases in the original, while mini-
mizing the number of non-DHS bases considered for the
downstream analysis. Our approach created approxi-
mately 550,000 windows for differential analysis among
five replicates (three LNCaP, two LNCaP-induced). The
number of tags mapping to each window in each repli-
cate were extracted, and regions with a sum total of less
than five reads were eliminated. We then used edgeR to
call windows with significantly different counts in each
pairwise comparison at two thresholds: strict (FDR <
0.05) and loose (unadjusted P < 0.05). Finally, neighbor-
ing windows that were identified as having a significantly
higher DNase-seq signal in a condition were merged. To
generate a normalized differential tag count for regions,
the number of DNase-seq tags within each LNCaP and
LNCaP-induced DHS region was determined and nor-
malized to the average number of tags in either all
LNCaP or LNCaP-induced DHS site. For each of the
175,796 union DHS regions, the normalized number of
tags in LNCaP in the region was subtracted from the nor-
malized number of tags in LNCaP-induced to give the
differential tag score for each region.
RNA expression analysis
RNA expression in response to androgen induction in
LNCaP was analyzed using both exon microarrays and
mRNA-seq. Total RNA was extracted using TRIzol
(Sigma-Aldrich, St. Louis, MO, USA) from the same cell
growth as used for DNase-seq and hybridized to Affyme-
trix Exon 1.0 ST arrays (Affymetrix, Santa Clara, CA,
USA) using a standard protocol. Resulting .CEL files were
summarized into expression measures at the gene-core
level using Affymetrix Power Tools and Robust Multi-
array Average (RMA) normalization [56]. Differential
expression upon androgen induction was determined
using the Statistical Analysis of Microarrays bioconductor
package [57]. Two biological replicates were processed for
exon array analysis.
RNA for use in mRNA-seq was isolated from three inde-
pendent growths of LNCaP with or without androgen
using the Ambion miRVANA miRNA isolation kit (Invi-
trogen, Grand Island, NY, USA). Induction of canonical
AR target gene expression was confirmed by qPCR, and
RNA quality was verified using an Agilent Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). All RNA
used for subsequent library preparation had an RNA
integrity number greater than 9.0. mRNA-seq libraries
were created using the Illumina mRNA-seq protocol and
kit then sequenced on the Illumina GAIIx platform.
Resulting sequence data was aligned to the human refer-
ence genome (NCBI Build 37) first using BWA [54]. Reads
unaligned by BWA were independently aligned with
TopHat [58] to only known and annotated splice junc-
tions. The results combined and filtered to remove non-
unique reads. Technical replicates were merged such that
three biological replicates (± androgen) were available for
subsequent analysis. The reads per kilobase mapped
expression measure was computed for each RefSeq gene
model in each replicate, leaving out tags mapping to the 3’
untranslated region of genes [59]. To identify RefSeq
genes differentially expressed between LNCaP and
LNCaP-induced cells, we first counted the number of
mRNA-seq tags that fell within exons of RefSeq gene
models in each biological replicate, resulting in a tag count
value for each gene. We then used the edgeR bioconduc-
tor package to detect genes whose expression differed with
AR activation, FDR < 0.05.
Correlation of ΔDNase increases and decreases with
expression increases and decreases
To establish the relationship between differential chro-
matin and differential expression, we tested for signifi-
cance in overlap in both directions, that is, we tested if
ΔDNase regions tend to be located near differentially
expressed genes, and then tested if differentially
expressed genes tend to have a ΔDNase region nearby.
We first assigned each DHS site to its nearest gene and
intersected these nearest genes with each AR-regulated
gene set (AR mRNA-seq upregulated, AR mRNA-seq
downregulated, and four sets from Massie et al. [40]:
Massie early up, Massie early down, Massie late up, Mas-
sie late down). We calculated the significance of the
ΔDNase association to differentially regulated genes by
permuting the set of all RefSeq genes 100,000 times, ran-
domly selecting the number of genes for each compari-
son, and intersecting those random sets with the genes
related to AR-induced expression changes. This estab-
lished a null distribution of overlaps in random inter-
sects. We also conducted the same analysis in the
opposite direction to relate expression change ΔDNase
regions. Using the University of California Santa Cruz
(UCSC) Known Genes table, we merged all isoform coor-
dinates for each gene and found all ΔDNase increase or
decrease sites within a surrounding 20 kb window. We
calculated pairwise overlaps of ΔDNase sites between
each ΔDNase increase or decrease list and these lists of
all nearby ΔDNase sites. If a gene contained a ΔDNase
site within 20 kb, it was counted as a match. We then
permuted genes located all nearby DHS sites 1,000 times,
and tested for overlap to create a null distribution of
overlap count.
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Androgen receptor ChIP-seq
AR ChIP-seq data was obtained from accession numbers
[GSE14097] and [GSE28126] through the NCBI Gene
Expression Omnibus portal. [GSE28126] was recently pub-
lished [40] as part of a study identifying AR ChIP-seq
peaks in LNCaP cells after 4 hours of 1 nM R1881 stimu-
lation. [GSE14097] [39] contains AR ChIP-seq data from
LNCaP cells treated with either 10 nM R1881 for 16 hours
or vehicle for the same length of time. Coetzee AR ChIP-
seq was conducted after 4 hours of either 10 nM dihydro-
testosterone or ethanol treatment of LNCaP cells [17,41].
Raw sequence files were processed through the same pipe-
line as our DNase-seq data [31] to obtain aligned
sequences. Model-based analysis for ChIP-seq (MACS)
[60] was used with default parameters to identify regions
of significant AR ChIP enrichment in LNCaP-induced
relative to LNCaP. To generate the common AR peaks
list, we intersected the peak calls from the two data sets,
considering peaks to be overlapping if they intersect by at
least one base pair.
Self-organizing maps
To identify DHS sites specific to our two cell types, we
used a SOM built from DNase-seq data generated by our
group from 113 lines [61]. SOMs are artificial neural net-
works that learn patterns in data by iteratively assigning
data points to cluster centers. The SOM eventually assigns
each DHS site to a cluster with the most similar hypersen-
sitivity profile. We are using SOMs to characterize DNase
I hypersensitivity profiles across over 100 cell lines (NS, in
preparation). For this analysis, we were interested in clus-
ters specific to LNCaP cell lines. We first built a data
matrix by counting the number of reads mapping in each
peak region in each cell type. We quantile-normalized the
scores by cell type and then capped them at the 99th
quantile (by setting the top 1% of scores to a maximum
value), and then row-scaled the scores to a decimal
between 0 and 1. After normalization, capping and scaling,
we built an SOM using the Kohonen package in R. This
SOM used a hexagonal 50 × 50 grid (for 2,500 total
nodes). We then took each node and selected the 50
regions closest in distance to the node center, and sub-
mitted these to MEME for de novo motif analysis [62]. We
then matched these motifs to publicly available DNA
binding motifs in TRANSFAC 7.0 [63] and JASPAR 2010
[64] using STAMP [65].
Motif analysis
To determine motif enrichment in regions of interest we
utilized used three algorithms: MEME, cERMIT [66], and
CentDist [67]. MEME and cERMIT report identified DNA
motifs not matched to known motifs. If MEME was run
on regions falling within DHS sites (all but analysis in
Figure 3e), we used a first order background model
common to DHS sites. cERMIT was run using ΔDNase
P-value as evidence for directing motif analysis. CentDist
identifies motifs enriched within a region and ranks them
relative to their distribution within each region, reporting
publicly available motifs that are found in regions. Motifs
identified in Figures 2 and 3 were identified in at least two
of these algorithms. If a motif was reported as enriched by
MEME and cERMIT, it was included in our results if its
match to publicly known motifs, determined by STAMP
or TomTom (using JASPAR and Uniprobe databases)
[68], was significant (E < 0.05). Results from CentDist are
shown in Table S3 in Additional file 1.
Androgen receptor footprint analysis
To generate an aggregate plot of DNase-seq signal around
AR motifs, we scanned DHS regions containing AR bind-
ing sites using a first order log likelihood scanner with a
slightly modified AR position weight matrix (PWM) from
the JASPAR database. The MA0007.1 matrix was trimmed
by discarding low information base pair positions sur-
rounding positions 4 to 18, resulting in a 15 bp PWM.
PWM motif scores that scored lower than the 90th percen-
tile of all match scores were discarded, and the strand with
the stronger PWM match was chosen if both strands at a
location matched the PWM within the 90th percentile or
higher. DNase-seq reads mapping to each base at the
motif site and surrounding 100 bp were collected and the
sum of each position was calculated.
For cluster correlation analysis, the k-means algorithm
[69] was run 100 times to yield k × 100 cluster centers,
where each cluster center is a vector of values of length 31
(clustering was performed on DNase-seq signal mapping
to 15 bp on both sides of center of AR motif). Cluster cen-
ters from one run i to all other runs (1, ..., i-1, i+1, ..., 100)
were compared. Each cluster center from a single run was
matched to another cluster center in another run in a pair-
wise manner that identifies maximum correlation; this
procedure was performed across all pairs of runs to assess
the similarity and reproducibility of results over multiple
runs of the algorithm.
For aggregate visualization of clusters, we tabulated
DNase-seq tag counts 100 bp around AR PWM matches
classified into each cluster within ‘R1881 intersect’ ChIP
peaks that were DHS in both LNCaP-induced and LNCaP.
MEME was used to search for de novo motifs 25 bp up-
and downstream from PWMs classified into each cluster.
TomTom was used to match significant motif matches to
publicly available motifs (E < 0.05).
Data access
DNase-seq data from this study can be visualized using
the UCSC Genome Browser [70]. Specifically, click on
the ‘Genome Browser’ option then click on the ‘configure
tracks and display’ button. Under the section entitled
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‘Regulation’, find the subsection ‘ENC DNase/FAIRE’ for
ENCODE Open Chromatin by DNase I HS and FAIRE,
and then click on the ‘Duke DNaseI HS’ link. In the
menu of cell lines that will appear, click on the two boxes
in the row labeled LNCaP (one for ‘no treatment’ and
one for ‘methyltrienelone (androgen)’), and this will allow
for data visualization. Processed and raw DNase-seq data
has also been deposited through the NCBI GEO website
under accession number [GSE32970]. Within that acces-
sion number, data for LNCaP is available under
[GSM816637] (Duke_DnaseSeq_LNCaP), and data for
LNCaP-induced is available under [GSM816634] (Duke_
DnaseSeq_LNCaP_androgen). Exon array expression data
is publicly available through the NCBI GEO website under
accession number GSE15805. Within this accession num-
ber, the two LNCaP replicates are under GSM443919 and
GSM443920, and the two LNCaP-induced replicates are
under GSM443921 and GSM443922. mRNA-seq data
from this study is available through the NCBI GEO website
under accession number GSE34780.
Additional material
Additional file 1: Supplemental information containing four
supplemental figures and three supplemental tables.
Additional file 2: Table S4 detailing RefSeq genes identified as
differentially expressed in response to androgen receptor activation
by mRNA-seq. mRNA from three biological replicates of LNCaP and
three biological replicates of LNCaP-induced was extracted and
sequenced. Genes differentially regulated by AR activation were
determined using edgeR at a threshold of FDR < 0.05.
Additional file 3: Table S5 showing a comparison of androgen
receptor-regulated genes as determined by mRNA-seq to
previously published androgen receptor-regulated gene lists. Genes
identified as differentially regulated by AR activation are shown along
with all other RefSeq genes, ranked in order by the number of published
studies that identify the gene as AR-regulated.
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